Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Cyrus Khan"'
Autor:
Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Michael Dickinson, Emmanuel Bachy, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquín Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua Brody, Sirpa Leppa, Pauline Baumlin, Linda Lundberg, James Relf, Yuying Xie, Alessia Bottos, Kathryn Humphrey, Lorenzo Falchi
Publikováno v:
HemaSphere, Vol 7, p e458981a (2023)
Externí odkaz:
https://doaj.org/article/c4495cc7d2714f60818218c0cb6a1f50
Autor:
Anas Younes, John M. Burke, Bruce D. Cheson, Catherine S. Diefenbach, Silvia Ferrari, Uwe H. Hahn, Eliza A. Hawkes, Cyrus Khan, Izidore S. Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam Yuen, Aparna Raval, Mahesh Shivhare, Tina G. Nielsen, Gila Sellam, Jeff P. Sharman
Publikováno v:
Blood Advances. 7:1488-1495
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the current standard therapy for patients with diffuse large B-cell lymphoma (DLBCL) and is curative in ∼60% of patients. Atezolizumab is a humanized immunoglobul
Publikováno v:
Journal of Hematology. 12:87-91
Autor:
Muath, Abdeen, Urwat Til, Vusqa, Palash, Asawa, Kiley, Felton, Derek, Rinchuse, Cyrus, Khan, Yazan, Samhouri, John, Lister
Publikováno v:
Anti-Cancer Drugs. 33:1167-1170
Venetoclax, a highly selective Bcl-2 inhibitor, is an orally bioavailable drug that has been approved as first-line therapy for chronic lymphocytic leukemia (CLL) in combination with obinutuzumab, as well as monotherapy in the setting of relapsed CLL
Autor:
Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Krish Patel, Mark Hertzberg, Lorenzo Falchi, Nancy L. Bartlett, Joshua Brody, Linda Lundberg, Yuying Xie, Estefania Mulvihill, Pauline Baumlin, James Relf, Emily Piccione, Kathryn Humphrey, Michael Dickinson
Publikováno v:
Blood. 140:1062-1064
Autor:
Moaath K. Mustafa Ali, Yazan Samhouri, Jennie Y. Law, Cyrus Khan, Rodney Wegner, Seung Tae Lee, John Lister
Publikováno v:
Breast Cancer. 29:1022-1031
Primary breast lymphoma (PBL) is managed differently among centers, using surgery, systemic therapy and/or radiation. With data derived from the National Cancer Database (NCDB), we aim to describe treatments utilized in the United States, estimate th
Primary CNS lymphoma (PCNSL) is an aggressive form of extranodal non-Hodgkin lymphoma that arises in the brain parenchyma, eyes, meninges, or spinal cord in the absence of systemic disease. Primary dural lymphoma (PDL) arises from the dura mater of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::185279a12416a1629447cf7463ec4093
https://doi.org/10.21203/rs.3.rs-2610064/v1
https://doi.org/10.21203/rs.3.rs-2610064/v1
Autor:
Yazan, Samhouri, Moaath K, Mustafa Ali, Cyrus, Khan, Rodney, Wegner, Seung Tae, Lee, John, Lister
Publikováno v:
Anticancer Research. 42:1867-1877
The addition of radiation to chemotherapy in elderly patients with primary central nervous system lymphoma (PCNSL) remains controversial. This aim of this study was to assess the trend of combined modality treatment (CMT) and compare its survival wit
Autor:
Michael J. Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Tomasz Wróbel, Fritz Offner, Marek Trněný, Shang-Ju Wu, Guillaume Cartron, Mark Hertzberg, Anna Sureda, David Perez-Callejo, Linda Lundberg, James Relf, Mark Dixon, Emma Clark, Kathryn Humphrey, Martin Hutchings
Publikováno v:
NEW ENGLAND JOURNAL OF MEDICINE
New England Journal of Medicine
New England Journal of Medicine, 2022, New England Journal of Medicine, 387, pp.2220-2231. ⟨10.1056/NEJMoa2206913⟩
New England Journal of Medicine
New England Journal of Medicine, 2022, New England Journal of Medicine, 387, pp.2220-2231. ⟨10.1056/NEJMoa2206913⟩
BackgroundThe prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is poor. Glofitamab is a bispecific antibody that recruits T cells to tumor cells.MethodsIn the phase 2 part of a phase 1-2 study, we enrolled pati
Autor:
Maitreyee Rai, Ryan Sweeney, Prerna Mewawalla, Santhosh Sadashiv, Gina Patrus, Charlene Briedenbaugh, Yazan Samhouri, Anna Koget, Cyrus Khan, Salman Fazal, John Lister
Publikováno v:
Transplantation and Cellular Therapy. 29:S182-S183